Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200046648> ?p ?o ?g. }
- W4200046648 endingPage "102996" @default.
- W4200046648 startingPage "102996" @default.
- W4200046648 abstract "Oseltamivir phosphate (OSE) is an antiviral drug that also can inhibit tumor vascularization, growth and metastasis. The target of the present research was the delivery of OSE into the lung adenocarcinoma cells by means of developing nanosized, biocompatible and stealth nanoarchitectonics of pegylated PLGA NPs. For this goal, OSE encapsulated nanoarchitectonics of pegylated PLGA NPs were formulated and investigated for zeta potential, particle size, encapsulation efficiency, DSC, FT-IR, 1H-NMR and SEM analyses. In vitro release, cytotoxicity, determination of apoptotic pathways and in vivo CAM assay were carried out. NPs exhibited smaller particle size, relatively higher EE%, spherical shape, amorphous matrix formation and biphasic prolonged release pattern (fitted Peppas-Sahlin and Weibull model). All NPs was found as 103 times more effective than OSE on cancerous cells. Flow cytometry was employed to evaluate the apoptotic pathways using the Annexin V-FITC/PI, FITC Active Caspase-3 staining assay and mitochondrial membrane potential determination tests. Activations on caspase-3 pathways made us think that OSE loaded pegylated PLGA NPs triggered to apoptosis using intrinsic pathway. Upon in vivo studies, PLGA-OSE 3 demonstrated moderate antiangiogenic activity. These results indicate that OSE loaded PLGA NPs (especially PLGA-OSE 3) were chosen as a promising candidate and a potent formulation to treat lung cancer." @default.
- W4200046648 created "2021-12-31" @default.
- W4200046648 creator A5015589520 @default.
- W4200046648 creator A5030894826 @default.
- W4200046648 creator A5080219288 @default.
- W4200046648 creator A5083635559 @default.
- W4200046648 date "2022-01-01" @default.
- W4200046648 modified "2023-10-02" @default.
- W4200046648 title "Nanoarchitectonics of PLGA based polymeric nanoparticles with oseltamivir phosphate for lung cancer therapy: In vitro-in vivo evaluation" @default.
- W4200046648 cites W1750851387 @default.
- W4200046648 cites W1787537274 @default.
- W4200046648 cites W1892150120 @default.
- W4200046648 cites W1979472449 @default.
- W4200046648 cites W1984856798 @default.
- W4200046648 cites W1992138503 @default.
- W4200046648 cites W1995258988 @default.
- W4200046648 cites W1995634417 @default.
- W4200046648 cites W2000307014 @default.
- W4200046648 cites W2001411844 @default.
- W4200046648 cites W2004187991 @default.
- W4200046648 cites W2006626262 @default.
- W4200046648 cites W2008757142 @default.
- W4200046648 cites W2009845520 @default.
- W4200046648 cites W2009974403 @default.
- W4200046648 cites W2012506930 @default.
- W4200046648 cites W2020398834 @default.
- W4200046648 cites W2020771429 @default.
- W4200046648 cites W2023671240 @default.
- W4200046648 cites W2026101888 @default.
- W4200046648 cites W2032760352 @default.
- W4200046648 cites W2034915619 @default.
- W4200046648 cites W2051011074 @default.
- W4200046648 cites W2051881319 @default.
- W4200046648 cites W2053152637 @default.
- W4200046648 cites W2065744879 @default.
- W4200046648 cites W2069124347 @default.
- W4200046648 cites W2076313217 @default.
- W4200046648 cites W2082511916 @default.
- W4200046648 cites W2092680496 @default.
- W4200046648 cites W2095359278 @default.
- W4200046648 cites W2109872018 @default.
- W4200046648 cites W2114918609 @default.
- W4200046648 cites W2115439624 @default.
- W4200046648 cites W2117437539 @default.
- W4200046648 cites W2118476975 @default.
- W4200046648 cites W2139169365 @default.
- W4200046648 cites W2154335294 @default.
- W4200046648 cites W2154882995 @default.
- W4200046648 cites W2169965478 @default.
- W4200046648 cites W2173044124 @default.
- W4200046648 cites W2209638 @default.
- W4200046648 cites W2286594751 @default.
- W4200046648 cites W2292885392 @default.
- W4200046648 cites W2325992502 @default.
- W4200046648 cites W2383968316 @default.
- W4200046648 cites W2414781026 @default.
- W4200046648 cites W2470610043 @default.
- W4200046648 cites W2508412777 @default.
- W4200046648 cites W2587001473 @default.
- W4200046648 cites W2741339609 @default.
- W4200046648 cites W2763904605 @default.
- W4200046648 cites W2788610544 @default.
- W4200046648 cites W2810546725 @default.
- W4200046648 cites W2884086646 @default.
- W4200046648 cites W2884954281 @default.
- W4200046648 cites W2898479620 @default.
- W4200046648 cites W2898712541 @default.
- W4200046648 cites W2918110300 @default.
- W4200046648 cites W2938453597 @default.
- W4200046648 cites W2957984348 @default.
- W4200046648 cites W2961537769 @default.
- W4200046648 cites W2999417355 @default.
- W4200046648 cites W3020290982 @default.
- W4200046648 cites W3032406344 @default.
- W4200046648 cites W3093690802 @default.
- W4200046648 cites W3093948233 @default.
- W4200046648 cites W3131577616 @default.
- W4200046648 cites W3135493399 @default.
- W4200046648 cites W3211038370 @default.
- W4200046648 doi "https://doi.org/10.1016/j.jddst.2021.102996" @default.
- W4200046648 hasPublicationYear "2022" @default.
- W4200046648 type Work @default.
- W4200046648 citedByCount "3" @default.
- W4200046648 countsByYear W42000466482022 @default.
- W4200046648 countsByYear W42000466482023 @default.
- W4200046648 crossrefType "journal-article" @default.
- W4200046648 hasAuthorship W4200046648A5015589520 @default.
- W4200046648 hasAuthorship W4200046648A5030894826 @default.
- W4200046648 hasAuthorship W4200046648A5080219288 @default.
- W4200046648 hasAuthorship W4200046648A5083635559 @default.
- W4200046648 hasConcept C109316439 @default.
- W4200046648 hasConcept C121608353 @default.
- W4200046648 hasConcept C12554922 @default.
- W4200046648 hasConcept C126322002 @default.
- W4200046648 hasConcept C15083742 @default.
- W4200046648 hasConcept C150903083 @default.
- W4200046648 hasConcept C155672457 @default.
- W4200046648 hasConcept C171250308 @default.